Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Mereo Biopharma Group Plc ADR (NASDAQ: MREO) was $1.92 for the day, down -8.57% from the previous closing price of $2.1. In other words, the price has decreased by -$8.57 from its previous closing price. On the day, 3.05 million shares were traded. MREO stock price reached its highest trading level at $2.1299 during the session, while it also had its lowest trading level at $1.885.
Ratios:
Our analysis of MREO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.71 and its Current Ratio is at 8.71. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, JP Morgan on March 27, 2025, initiated with a Overweight rating and assigned the stock a target price of $7.
On December 06, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $7.
On June 13, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $8.Robert W. Baird initiated its Outperform rating on June 13, 2024, with a $8 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MREO now has a Market Capitalization of 305532864 and an Enterprise Value of 1479363328. For the stock, the TTM Price-to-Sale (P/S) ratio is 598.96 while its Price-to-Book (P/B) ratio in mrq is 6.56. Its current Enterprise Value per Revenue stands at 2958.727 whereas that against EBITDA is -32.854.
Stock Price History:
The Beta on a monthly basis for MREO is 0.26, which has changed by -0.36170214 over the last 52 weeks, in comparison to a change of 0.15905356 over the same period for the S&P500. Over the past 52 weeks, MREO has reached a high of $3.88, while it has fallen to a 52-week low of $1.47. The 50-Day Moving Average of the stock is -1.58%, while the 200-Day Moving Average is calculated to be -9.06%.
Shares Statistics:
MREO traded an average of 1.69M shares per day over the past three months and 3118490 shares per day over the past ten days. A total of 159.10M shares are outstanding, with a floating share count of 137.51M. Insiders hold about 13.57% of the company’s shares, while institutions hold 57.43% stake in the company. Shares short for MREO as of 1764288000 were 9207930 with a Short Ratio of 5.46, compared to 1761868800 on 10121542. Therefore, it implies a Short% of Shares Outstanding of 9207930 and a Short% of Float of 8.129999999999999.
Earnings Estimates
. The current assessment of Mereo Biopharma Group Plc ADR (MREO) involves the perspectives of 6.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.0, with high estimates of $0.04 and low estimates of -$0.01.
Analysts are recommending an EPS of between -$0.01 and -$0.05 for the fiscal current year, implying an average EPS of -$0.04. EPS for the following year is -$0.01, with 5.0 analysts recommending between $0.1 and -$0.05.
